GO:0034975 protein folding in endoplasmic reticulum: Protein Synthesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034975 describes the protein folding process that occurs in the endoplasmic reticulum (ER), where secreted, plasma membrane and organelle proteins acquire their native conformations assisted by chaperones, foldases, ATP, Ca2+ and an oxidizing environment.
• ER protein folding is essential for proteostasis and is tightly coupled to the unfolded protein response (UPR), which adjusts folding capacity to demand.
• Oxidative protein folding in the ER relies on disulfide bond formation and reductive pathways that maintain redox homeostasis, and its fidelity is critical for protein function.
• Failure of ER protein folding underlies diverse human diseases including neurodegeneration, diabetes, cancer and inflammatory disorders.
• Key ER folding factors include HSPA5 (BiP), HSP90B1 (GRP94), PDIA family members, CALR, CANX and ERO1A, which can be targeted by CRISPR knockout, point mutation, knock-in or overexpression models.
• Studying GO:0034975 requires integrating transcriptomics, proteomics, imaging and functional assays, often enabled by CRISPR-engineered cell models.
Description
The endoplasmic reticulum (ER) is the primary site for folding and maturation of proteins destined for the secretory pathway, the plasma membrane and organelles. The Gene Ontology term GO:0034975, protein folding in endoplasmic reticulum, captures the biological process by which these proteins attain their native three-dimensional structures within the ER lumen, assisted by chaperones, foldases and an optimized environment. This process is fundamental to cellular proteostasis and is conserved across eukaryotes. ER protein folding is not merely a housekeeping function; it is a regulated and stress-responsive process. The ER folding machinery must match the load of newly synthesized polypeptides, and imbalances trigger the unfolded protein response (UPR), a signaling network that adjusts folding capacity, degradation and translation. Because approximately one-third of the proteome passes through the ER, defects in this process have broad physiological consequences. Research into GO:0034975 spans molecular chaperones, oxidoreductases, calcium homeostasis and redox regulation. Understanding how these components cooperate is essential for dissecting diseases such as neurodegeneration, cancer and metabolic disorders, and for developing therapeutic strategies that target ER proteostasis.
protein folding in endoplasmic reticulum At A Glance
| GO ID | GO:0034975 |
|---|---|
| GO term | protein folding in endoplasmic reticulum |
| Ontology | biological_process |
| Synonym | oxidative protein folding; protein folding in ER |
| Major function | Folding of secreted, plasma membrane and organelle proteins in the ER lumen |
| Key cofactors | ATP, Ca2+, oxidizing environment for disulfide bond formation |
| Major chaperones/foldases | HSPA5 (BiP), HSP90B1 (GRP94), PDIA family, CALR, CANX, ERO1A |
| Associated pathway | Unfolded protein response (UPR) and ER-associated degradation (ERAD) |
| Cellular location | Endoplasmic reticulum lumen and membrane |
What Is GO:0034975?
GO:0034975 (protein folding in endoplasmic reticulum) is defined as a protein folding process that takes place in the endoplasmic reticulum (ER). Secreted, plasma membrane and organelle proteins are folded in the ER, assisted by chaperones and foldases (protein disulphide isomerases), and additional factors required for optimal folding, including ATP, Ca2+ and an oxidizing environment to allow disulfide bond formation. In simpler terms, it is the set of molecular events inside the ER that helps newly made proteins achieve their correct shape and stability before they are transported to their final destinations.
Why Is protein folding in endoplasmic reticulum Important in Cell Biology?
Protein folding in the endoplasmic reticulum is essential for the biogenesis of a large fraction of the eukaryotic proteome, including hormones, receptors, transporters and extracellular matrix components. Because ER folding capacity is limited and tightly regulated, its dysfunction leads to accumulation of misfolded proteins, ER stress and activation of the UPR, which can either restore homeostasis or trigger apoptosis. This process is therefore central to cell survival, differentiation and immune function, and its dysregulation is implicated in a wide range of human diseases, from neurodegeneration to cancer.
• Enables correct folding of secreted and membrane proteins, which represent roughly one-third of the proteome.
• Maintains ER proteostasis through chaperones, foldases and quality control pathways.
• Activates the UPR to adapt folding capacity to physiological demand and stress.
• Supports disulfide bond formation and redox homeostasis via oxidative folding machinery.
• Dysregulation contributes to neurodegenerative diseases such as Alzheimer's and Parkinson's.
• Plays a role in cancer cell survival and adaptation to microenvironmental stress.
• Impacts metabolic disorders including diabetes through ER stress in pancreatic beta cells.
• Provides targets for therapeutic modulation of ER folding in rare and common diseases.
• Is conserved in plants, where oxidative protein folding supports stress responses.
• Can be studied with CRISPR screens to identify novel folding factors and disease modifiers.
What Happens During protein folding in endoplasmic reticulum?
Substrate entry and N-linked glycosylation
In simple terms: New proteins enter the ER and get tagged with sugar chains that help them fold.
Nascent polypeptides destined for the secretory pathway are translocated into the ER lumen, where they undergo N-linked glycosylation and initial folding attempts. These early modifications facilitate interactions with lectin chaperones such as calnexin (CANX) and calreticulin (CALR), which promote proper folding and retain incompletely folded species in the ER.
Chaperone-assisted folding and ATP-dependent cycles
In simple terms: Molecular chaperones use energy to help proteins fold correctly and prevent aggregation.
The Hsp70-family chaperone HSPA5 (BiP) binds exposed hydrophobic regions of folding intermediates and, through ATP-dependent cycles, prevents aggregation and supports folding. HSP90B1 (GRP94) assists a subset of client proteins, and co-chaperones and nucleotide exchange factors regulate these cycles to match folding demand.
Oxidative folding and disulfide bond formation
In simple terms: The ER's oxidizing environment allows stabilizing disulfide bonds to form between cysteine residues.
Protein disulfide isomerases (PDIA family) catalyze disulfide bond formation, reduction and isomerization, while ERO1A generates oxidizing equivalents and transfers them to PDIs. This oxidative folding pathway is essential for the stability of many secreted and membrane proteins, and its fidelity is maintained by reductive pathways that prevent hyperoxidation. In plants, similar oxidative folding mechanisms operate in the ER and contribute to stress responses.
Calcium homeostasis and folding environment
In simple terms: Calcium levels in the ER help chaperones work properly.
The ER lumen maintains high Ca2+ concentrations that are required for the activity of several chaperones and foldases, including CALR and CANX. Disturbances in ER calcium homeostasis impair protein folding and activate the UPR, linking calcium signaling to proteostasis.
Quality control and ER-associated degradation
In simple terms: Proteins that fail to fold are recognized and destroyed.
Terminally misfolded proteins are recognized by ER quality control machinery and retrotranslocated to the cytosol for ubiquitination and degradation by the proteasome, a process known as ER-associated degradation (ERAD). This quality control is coordinated with the UPR to maintain ER homeostasis and prevent toxic accumulation of misfolded proteins.
Unfolded protein response and adaptive regulation
In simple terms: When folding demand exceeds capacity, the cell activates a stress response to restore balance.
The UPR is mediated by three main sensors (ERN1/IRE1, EIF2AK3/PERK and ATF6) that detect unfolded proteins and trigger transcriptional and translational programs to increase folding capacity, reduce protein load and enhance degradation. This adaptive response is critical for surviving ER stress and is tightly linked to GO:0034975.
Key Genes Involved in GO:0034975 protein folding in endoplasmic reticulum
The following genes encode core components and regulators of protein folding in the endoplasmic reticulum (GO:0034975), representing major chaperones, foldases, redox regulators and UPR sensors.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HSPA5 | ER Hsp70 chaperone (BiP); binds hydrophobic regions and regulates UPR sensors | Central to folding and ER stress; frequent target in KO and overexpression studies |
| HSP90B1 | ER Hsp90 chaperone (GRP94); assists client protein maturation | Implicated in cancer and immune function; used in folding studies |
| PDIA3 | Protein disulfide isomerase; catalyzes disulfide bond formation and isomerization | Key oxidative folding enzyme; target for redox studies |
| PDIA4 | Protein disulfide isomerase family member; supports oxidative folding | Modulates ER redox and folding capacity |
| PDIA6 | Protein disulfide isomerase; regulates UPR and disulfide reduction | Links oxidative folding to UPR signaling |
| ERO1A | Oxidoreductin; generates oxidizing equivalents for PDIs | Essential for oxidative folding; knockout causes ER stress |
| CALR | Calcium-binding lectin chaperone; assists glycoprotein folding | Involved in calcium homeostasis and immunogenicity |
| CANX | Calnexin; membrane-bound lectin chaperone for glycoprotein folding | Quality control of glycoproteins |
| ERN1 | IRE1; UPR sensor and endoribonuclease | Mediates adaptive UPR signaling |
| EIF2AK3 | PERK; UPR sensor that phosphorylates eIF2alpha | Regulates translation during ER stress |
| ATF6 | UPR sensor and transcription factor | Induces chaperone and foldase genes |
| XBP1 | Transcription factor downstream of IRE1; expands ER folding capacity | Key UPR effector; knockout models available |
| ATF4 | Transcription factor downstream of PERK; regulates stress response genes | Links ER stress to amino acid metabolism and apoptosis |
| DNAJB9 | ER co-chaperone; assists BiP in folding and degradation | Modulates ER quality control |
| SEL1L | Component of ERAD complex; recognizes misfolded proteins | ERAD and quality control studies |
| SYVN1 | ERAD E3 ubiquitin ligase; targets misfolded proteins for degradation | ER quality control and degradation |
| EDEM1 | ER degradation-enhancing alpha-mannosidase-like protein; targets misfolded glycoproteins | ERAD of glycoproteins |
How Is protein folding in endoplasmic reticulum Regulated?
Protein folding in the endoplasmic reticulum is regulated at multiple levels to match folding demand. The unfolded protein response (UPR) is the primary adaptive pathway: ERN1 (IRE1), EIF2AK3 (PERK) and ATF6 sense unfolded proteins and activate transcriptional and translational programs that increase chaperone and foldase expression, enhance ERAD and reduce protein synthesis. The UPR also crosstalks with calcium signaling, redox regulation and metabolic pathways to maintain ER homeostasis. Additionally, AMPylation of BiP by FICD modulates chaperone activity and ER folding homeostasis, providing a reversible regulatory mechanism. In plants, oxidative protein folding is similarly regulated by redox and stress signals.
protein folding in endoplasmic reticulum and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HSPA5 | Neurodegeneration, cancer, ER stress | Knockout and overexpression cell lines; UPR reporter assays |
| ERO1A | Cancer, oxidative folding defects | Knockout and point mutation models; redox probes |
| ERN1 | Neurodegeneration, metabolic disease | Knockout and knock-in of UPR sensor; stress assays |
| XBP1 | Inflammatory bowel disease, cancer | Knockout and overexpression; transcriptomics |
| PDIA3 | Cancer, immune disorders | Knockout and point mutation; disulfide bond analysis |
Neurodegeneration and ER proteostasis
Chronic ER stress and impaired protein folding in the ER contribute to neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis, where misfolded proteins accumulate and overwhelm quality control pathways. UPR dysregulation is a common feature in these disorders, and genetic or pharmacological modulation of ER folding factors can influence neuronal survival.
Cancer and ER stress adaptation
Cancer cells often face hypoxia, nutrient deprivation and high secretory demand, leading to chronic ER stress. They adapt by activating the UPR and enhancing ER folding capacity, which supports survival and chemoresistance. Targeting ER folding machinery, such as HSPA5 or ERO1A, is being explored as a therapeutic strategy.
Metabolic and inflammatory disorders
ER stress in pancreatic beta cells contributes to insulin resistance and diabetes, while in immune cells it modulates inflammatory signaling. Defects in ER folding and UPR components have been linked to inflammatory bowel disease and other immune-mediated conditions.
Rare diseases and ER storage disorders
Mutations in genes encoding ER folding factors or their substrates can cause rare diseases, including protein misfolding disorders and ER storage diseases. Understanding these defects at the molecular level is essential for diagnosis and for developing targeted therapies.
From protein folding in endoplasmic reticulum-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a chaperone impair ER folding? | CRISPR knockout cell line (e.g., HSPA5 KO) |
| Does a disease-associated mutation alter foldase activity? | Point mutation knock-in (e.g., PDIA3 mutant) |
| Can a tagged folding factor be tracked in live cells? | Tagged knock-in (e.g., GFP-HSPA5) |
| Does overexpression of a foldase protect against ER stress? | Overexpression cell line (e.g., ERO1A) |
| Which genes modify ER stress sensitivity? | Genome-wide CRISPR library screening |
| How does UPR signaling change upon folding gene KO? | RNA-seq and Ribo-seq in KO models |
How to Study the protein folding in endoplasmic reticulum Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcript abundance and splicing | UPR target gene expression in KO models |
| Ribo-seq | Translation efficiency and ribosome occupancy | Translational control during ER stress |
| Proteomics | Protein abundance and interactions | Chaperone complex composition |
| Redox proteomics | Disulfide bond status and oxidation | Oxidative folding fidelity |
| Live-cell imaging | ER morphology and folding dynamics | Tagged chaperone localization |
| Pulse-chase | Folding and secretion kinetics | Substrate maturation in KO cells |
| UPR reporter assays | Stress pathway activation | Screening for folding modulators |
| CRISPR screens | Gene essentiality and modifiers | Discovery of novel folding factors |
Transcriptomic and translatomic profiling
RNA-seq and Ribo-seq can quantify changes in mRNA expression and translation efficiency of ER folding genes and UPR targets upon genetic perturbation. These methods help identify transcriptional programs that compensate for folding defects and reveal stress-responsive networks.
Proteomic and redox analyses
Mass spectrometry-based proteomics can assess protein abundance, interactions and post-translational modifications of ER folding factors. Redox proteomics and disulfide bond mapping specifically evaluate oxidative folding fidelity and redoxtasis.
Imaging and live-cell reporters
Fluorescence microscopy with tagged chaperones or ER stress reporters enables real-time monitoring of folding dynamics and ER morphology. Calcium imaging and redox-sensitive probes further dissect the ER folding environment.
Functional folding and stress assays
Pulse-chase labeling, luciferase refolding assays and UPR reporter systems measure folding kinetics and stress pathway activation. These assays are often combined with CRISPR knockouts to establish causality.
How CRISPR Can Be Used to Study GO:0034975 protein folding in endoplasmic reticulum
Knockout
CRISPR knockout of ER folding genes such as HSPA5, ERO1A or PDIA family members enables loss-of-function studies to determine their requirement for protein folding and cell survival. Knockout models are widely used to dissect UPR activation and ERAD capacity.
Point Mutation
Introducing disease-associated or catalytic point mutations into folding factors (e.g., PDIA3 active-site mutants) allows precise structure-function analysis of oxidative folding and chaperone activity. These models help distinguish folding defects from other functions.
Knock-in
Knock-in of tagged or reporter alleles (e.g., GFP-HSPA5) facilitates live-cell imaging and biochemical purification of folding complexes. Knock-in of patient mutations can model rare ER folding disorders.
Overexpression
Overexpression of chaperones or foldases such as HSPA5 or ERO1A can enhance ER folding capacity and protect against stress, providing gain-of-function models to test therapeutic hypotheses. These models are useful for studying adaptive UPR responses.
How EDITGENE Supports protein folding in endoplasmic reticulum Research
Researchers studying protein folding in endoplasmic reticulum-related genes often need to determine whether a candidate gene is causally involved in folding, stress adaptation or disease. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbations, from knockout to knock-in, to support mechanistic and translational studies of GO:0034975.
Contact EDITGENE today to design your custom CRISPR model for protein folding in endoplasmic reticulum research.
Frequently Asked Questions About protein folding in endoplasmic reticulum
What is protein folding in endoplasmic reticulum (GO:0034975)?
It is the biological process by which secreted, plasma membrane and organelle proteins fold into their native structures within the ER lumen, assisted by chaperones, foldases, ATP, Ca2+ and an oxidizing environment.
What genes are involved in protein folding in endoplasmic reticulum?
Key genes include HSPA5, HSP90B1, PDIA3, PDIA4, PDIA6, ERO1A, CALR, CANX, ERN1, EIF2AK3, ATF6 and XBP1.
Why is ER protein folding important?
It ensures proper biogenesis of a large fraction of the proteome and maintains proteostasis; its failure causes ER stress and is linked to many diseases.
How is ER protein folding regulated?
It is regulated by the unfolded protein response (UPR), calcium homeostasis, redox balance and AMPylation of BiP.
What happens when ER protein folding fails?
Misfolded proteins accumulate, triggering the UPR and ERAD; chronic failure can lead to apoptosis and disease.
Which diseases are linked to ER protein folding defects?
Neurodegenerative diseases, cancer, diabetes and inflammatory disorders are associated with ER folding dysfunction.
How can I study protein folding in the ER?
Methods include RNA-seq, Ribo-seq, proteomics, redox assays, imaging and CRISPR knockout models.
What is oxidative protein folding?
It is the formation of disulfide bonds in the ER catalyzed by protein disulfide isomerases and ERO1A, essential for protein stability.
Can CRISPR be used to study ER folding genes?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models enable precise functional studies of ER folding genes.
What is the role of BiP (HSPA5) in ER folding?
BiP binds hydrophobic regions of folding intermediates, prevents aggregation and regulates UPR sensors.
Conclusion
GO:0034975, protein folding in endoplasmic reticulum, is a central biological process that ensures the correct maturation of secreted and membrane proteins. It relies on a sophisticated network of chaperones, foldases, redox regulators and calcium-dependent factors, all coordinated with the unfolded protein response. Dysregulation of this process is implicated in major human diseases, making it a key area of biomedical research. Advances in CRISPR-based cell models, combined with multi-omics and imaging approaches, are accelerating the discovery of new folding factors and therapeutic targets. EDITGENE supports this research by providing customizable knockout, point mutation, knock-in, overexpression and library screening services tailored to ER folding studies.
References
- 1. Wang M et al.. 2016. Protein misfolding in the endoplasmic reticulum as a conduit to human disease.. Nature 529(7586):326-35 PMID: 26791723
- 2. Urade R. 2019. Oxidative protein folding in the plant endoplasmic reticulum.. Biosci Biotechnol Biochem 83(5):781-793 PMID: 30712483
- 3. Wang L et al.. 2023. Oxidative protein folding fidelity and redoxtasis in the endoplasmic reticulum.. Trends Biochem Sci 48(1):40-52 PMID: 35871147
- 4. Hetz C et al.. 2020. Mechanisms, regulation and functions of the unfolded protein response.. Nat Rev Mol Cell Biol 21(8):421-438 PMID: 32457508
- 5. Schwarz DS et al.. 2016. The endoplasmic reticulum: structure, function and response to cellular signaling.. Cell Mol Life Sci 73(1):79-94 PMID: 26433683
- 6. Braakman I et al.. 2013. Protein folding in the endoplasmic reticulum.. Cold Spring Harb Perspect Biol 5(5):a013201 PMID: 23637286
- 7. Perera LA et al.. 2023. AMPylation and Endoplasmic Reticulum Protein Folding Homeostasis.. Cold Spring Harb Perspect Biol 15(3) PMID: 36041787
- 8. Adams BM et al.. 2019. Protein Quality Control in the Endoplasmic Reticulum.. Protein J 38(3):317-329 PMID: 31004255
